Sulbactam/cefoperazone plus amikacin versus sulbactam/cefoperazone plus doxycycline: A microbiological study and well-controlled comparative clinical study on infection in association with lung cancer

Akira Watanabe, Yushi Nakai, Jun ichi Saito, Yoshihiro Honda, Yutaka Tokue, Mitsunobu Honma, Tsukasa Yoshida, Kenichi Takeuchi, Izumi Hayashi, Shigeo Takizawa, Kenji Yanase, Kotaro Oizumi, Yoichiro Ichikawa, Kazuma Fujino, Ken Araki, Masao Kawahara, Hiroshi Minami, Fumio Tanaka, Yoshiyuki Mitsutake, Toshihiro Higashi

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Sulbactam/cefoperazone plus amikacin versus sulbactam/cefoperazone plus doxycycline: A microbiological study and well-controlled comparative clinical study on infection in association with lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science